IDM confirms significant results in bladder cancer program.
D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D007167:Immunotherapy; D008262:Macrophage Activation / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D055502:Secondary Prevention; D001749:Urinary Bladder Neoplasms / Q000628:therapy*